When an industry undergoes a radical change because of the entrance of a disruptive technology, those too cumbersome to move fast enough, too conservative to move far enough, or too complacent to believe they need to move at all may find themselves clinging to a doomed business model as the market shifts beneath them. That is, until they have been left behind by both their competition and customers.
With the pharmaceutical sector currently in the middle of such a transformative cycle, are drug developers or the firms providing them with outsourced research or manufacturing services going to find themselves similarly left behind?
Table of Contents
4 WHAT IS DISRUPTIVE INNOVATION?
5 Bibliography
6 HOW TO DISRUPT YOUR OWN INDUSTRY
8 A RECENT HISTORY OF DISRUPTIVE INNOVATION IN PHARMA
9 Bibliography
10 OUTSOURCING AS DISRUPTION
11 THE PRESENT CYCLE OF DISRUPTIVE INNOVATION
11 Mobile technology
11 Clinical data standards
12 Risk-based monitoring
13 HOW CAN OUTSOURCING PROVIDERS PREPARE?
14 Bibliography
15 WHAT’S NEXT?